Body

Pill some day may prevent serious foodborne illness, scientist says

WEST LAFAYETTE, Ind. - Modified probiotics, the beneficial bacteria touted for their role in digestive health, could one day decrease the risk of Listeria infection in people with susceptible immune systems, according to Purdue University research.

Sensitive detection method analyzes circulating tumor cells in patients with lung cancer

SAN DIEGO — Researchers have developed a method to analyze circulating tumor cells in the blood of patients with non-small cell lung cancer. This method, which can analyze a sample size as small as three cells, may allow clinicians to track cancer progress and treatments and could help them develop new therapies.

Estrogen-targeting drug combo may help prevent lung cancer

SAN DIEGO -- A combination of drugs that target estrogen production significantly reduced the number of tobacco carcinogen-induced lung tumors in mice, according to results from a preclinical study.

Genetic composition of multicentric lung tumors appears to be similar

SAN DIEGO -- Multicentric carcinogenesis with the same genetic mutation appears to occur in lung adenocarcinoma, according to data presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine, held Jan. 8-11, 2012.

Data also demonstrated that the EGFR and KRAS genes, which are mutually exclusive, can be used to define clinically relevant molecular subsets of lung adenocarcinoma and can define tumor clonality.

Researchers map potential genetic origins, pathways of lung cancer in never-smokers

SAN DIEGO -- Researchers have begun to identify which mutations and pathway changes lead to lung cancer in never-smokers — a first step in developing potential therapeutic targets.

New way to learn about -- and potentially block -- traits in harmful pathogens

DURHAM, N.C. -- Researchers at Duke University Medical Center have developed a new way to identify the genes of harmful microbes, particularly those that have been difficult to study in the laboratory.

This new method uses chemicals to create mutant bacteria, followed by genomic sequencing to identify all mutations. By looking for common genes that were mutated in Chlamydia sharing a particular trait, the investigators were able to rapidly "zero in" on the genes responsible for that trait.

Protein complex plays role in suppressing pancreatic tumors, Stanford study shows

STANFORD, Calif. — A well-known protein complex responsible for controlling how DNA is expressed plays a previously unsuspected role in preventing pancreatic cancer, according to researchers at the Stanford University School of Medicine.

Study confirms new strategy in fight against infectious diseases

COLUMBUS, Ohio – New research shows that infectious disease-fighting drugs could be designed to block a pathogen's entry into cells rather than to kill the bug itself.

Historically, medications for infectious diseases have been designed to kill the offending pathogen. This new strategy is important, researchers say, because many parasites and bacteria can eventually mutate their way around drugs that target them, resulting in drug resistance.

Towards more effective treatment for multiple myeloma

A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent anti-tumor effects on multiple myeloma, a bone marrow cancer. Despite aggressive modes of treatments, myeloma ultimately remains incurable. The disease has a high incidence in the communities served by SUNY Downstate.

MU researchers find unique protein organization in arteries associated with cardiovascular disease

As people age, the level of elastin diminishes and other proteins, such as collagen, contribute to altering the arterial stiffness. The researchers believe that learning how to alter elastin levels may alleviate some of the detrimental results associated with vascular aging, such as high blood pressure.

Spasticity gene finding provides clues to causes of nerve cell degeneration

The discovery of a gene that causes a form of hereditary spastic paraplegia (HSP) may provide scientists with an important insight into what causes axons, the stems of our nerve cells, to degenerate in conditions such as multiple sclerosis.

Aria Diagnostics announces publication of first peer-reviewed data for new noninvasive prenatal test

San Jose, Calif., Jan. 9, 2012 – Aria Diagnostics (formerly Tandem Diagnostics), a molecular diagnostics company, today announced publication of data supporting a directed, non-invasive approach to cell-free DNA (cfDNA) analysis in maternal blood for evaluation of two common fetal trisomies linked to genetic disorders.

Wildlife Conservation Society announces new snake species

NEW YORK (DATE) -- The Wildlife Conservation Society (WCS) announced the discovery of a spectacularly colored snake from a remote area of Tanzania in East Africa.

The striking black-and-yellow snake is called Matilda's horned viper. It measures 2.1 feet (60 centimeters) and has horn-like scales above its eyes.

The discovery is described in the December issue of Zootaxa. Authors of the study include: Michele Menegon of Museo delle Scienze of Trento, Italy; Tim Davenport of the Wildlife Conservation Society; and Kim Howell of the University of Dar es Salaam.

In the brain, 'ORMOSIL' nanoparticles hold promise as a potential vehicle for drug delivery

BUFFALO, N.Y. -- In the images of fruit flies, clusters of neurons are all lit up, forming a brightly glowing network of highways within the brain.

It's exactly what University at Buffalo researcher Shermali Gunawardena was hoping to see: It meant that ORMOSIL, a novel class of nanoparticles, had successfully penetrated the insects' brains. And even after long-term exposure, the cells and the flies themselves remained unharmed.

The particles, which are tagged with fluorescent proteins, hold promise as a potential vehicle for drug delivery.

Cancer and fertility -- young women speak up

New York / Heidelberg, 9 January 2012 -- Young female cancer survivors are concerned about their future fertility and parenthood options and want better information and guidance early on, according to a new study by Jessica Gorman and her team from the University of California in the US. Their paper, which presents in-depth information on young survivors' experiences navigating decisions about fertility and parenthood, is published online in Springer's Journal of Cancer Survivorship.